InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Secora Michael, Chief Financial Officer. Officer active across 1 companies, notably Recursion Pharmaceuticals, INC.. Cumulatively, 3 disclosures have been published. The latest transaction was filed on 16 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€5,8061,069 shares@ €5.43160.0003% mcap100.0% of flow
Class A Common Stock
SEC:0001209191-22-030251:0·
058,342 shares0
Class A Common Stock
SEC:0001209191-22-007913:0·
058,342 shares0
Class A Common Stock
SEC:0001209191-22-007913·
3 of 3 declarations
About Secora Michael
Michael Secora is the Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. In this role, he is responsible for the financial management of the company, including budgeting and performance analysis. His expertise in the pharmaceutical sector is essential in supporting RECURSION's growth strategy. He also plays a key role in optimizing financial resources and ensuring regulatory compliance.
